Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study

Dose-dense early postoperative intraperitoneal chemotherapy (DD-EPIC) significantly increased non-progression rate in advanced ovarian cancer (OC) patients. We report final overall survival (OS) results to further strengthen the efficacy of DD-EPIC in the front-line therapy. In this phase 2 trial, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Tingyan, Jiang, Rong, Pu, Hong, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Cai, Yunlang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738091/
https://www.ncbi.nlm.nih.gov/pubmed/31383985
http://dx.doi.org/10.1038/s41416-019-0543-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738091/
https://www.ncbi.nlm.nih.gov/pubmed/31383985
http://dx.doi.org/10.1038/s41416-019-0543-1

Ejemplares similares